HOLMES HERBS INC
10SB12G, 2000-07-24
Previous: DAVIDS BRIDAL INC, SC 14D9/A, EX-99.A.4, 2000-07-24
Next: HOLMES HERBS INC, 10SB12G, EX-3.1, 2000-07-24




                          UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                      Washington, DC 20549

                           FORM 10-SB
           GENERAL FORM FOR REGISTRATION OF SECURITIES
                    OF SMALL BUSINESS ISSUERS

 Pursuant to Section 12(b) or (g) of the Securities and Exchange
                           Act of 1934

                                2









                       HOLMES HERBS, INC.
     (Exact name of registrant as specified in its charter)







Nevada                                            88-0412635
(State of organization) (I.R.S. Employer Identification No.)

3651 Lindell Rd., Suite A, Las Vegas, NV  89103
(Address of principal executive offices)

Registrant's telephone number, including area code (702) 873-7404

Securities to be registered pursuant to Section 12(b) of the Act:
None

Securities to be registered pursuant to Section 12(g) of the Act:
          Common stock, par value $.001 per share


ITEM 1.   DESCRIPTION OF BUSINESS

                           Background

HOLMES HERBS, INC. (the "Company") is a Nevada corporation formed
on  December 3, 1998. Its principal place of business is  located
at 3651 Lindell Rd., Suite A, Las Vegas, NV  89103.

                       Business of Issuer

The  Company  was  organized to engage in  any  lawful  corporate
business.  Since its inception, the Company's main  activity  has
been organizational.

The  Company  plans  to  engage  in  both  wholesale  and  retail
distribution  of herbal products beginning in Las Vegas,  Nevada.
The  Company will rely on newspaper advertisements and later will
use  e-commerce  to  implement  its  marketing  objectives.   The
Company  also  intends to utilize direct mailing  and  e-mail  to
solicit manufacturers and retailers of products.

The  company  has not yet introduced any products,  and  has  not
entered  into  agreements with any suppliers.  Once  the  Company
begins offering products for sale, it will face competition  from
existing  suppliers. Competition in these products  is  primarily
centered  on quality, price, brand recognition and service,  with
an   emphasis  on  the  service.  To  be  competitive  in   these
marketplaces, the Company must effectively maintain  and  promote
the  quality of both the products and service among consumers and
establish  strong marketing relationships with manufacturers  and
distributors of the products.  While the Company believes that it
will   compete   effectively,  many  of  the   competitors   have
substantially  greater  resources and  well  recognized  business
names.  The Company believes it can take advantage of its smaller
size to attract customers seeking more personalized service.  The
Company expects to attract customers via various internet  search
engines upon completion of various web pages.

                       Marketing Strategy

The  Company intends to engage in both the wholesale  and  retail
distribution  of  herbal  products.   The  Company   intends   to
initially  rely  on  newspaper advertisements  and  later  on  e-
commerce  to  implement the Company's marketing objectives.   The
Company  also  intends to utilize direct mailing, and  e-mail  to
solicit  manufacturers and Retailers of products  which  will  be
sold by the Company.

The   Company's  marketing  and  licensing  strategy  is  to  (i)
establish  and  expand  a clientele; (ii) expand  the  number  of
advertisements; and (iii) acquire or establish relationships with
major   manufacturers   businesses,  companies,   properties   or
technologies.

The   Company   will   purchase  most  of  its   inventory   from
manufacturers  principally in North America and the  Orient.   To
date,  no  contracts have been executed and the Company does  not
anticipate  entering into any contracts due to lack  of  funding.
Upon funding, letters of credit may be sought.

The   need  for  herbal  products  increases  as  the  increasing
population  has  begun returning to nature (herbs)  to  heal  any
ailments.  The Company does not anticipate being dependent on one
major  or  a  few major customers.  The business will  supply  to
major herbal retailers and the general public.  Also listing  the
web  page(s) throughout various search engines should provide the
Company with numerous business opportunities.

As  of  the date of this Registration Statement, the Company  has
one part time employee, who to this date has not entered into  an
employment  arrangement with the Company.  Due  to  the  lack  of
funding,  the  Company  has no collective  bargaining  agreements
covering  its  only  employee, has not experienced  any  material
labor  disruption  and  is unaware of any  efforts  or  plans  to
organize  its future employees.  The Company considers  relations
with its employee to be good.

Other  than  the early design stages of its website, the  Company
has no intellectual property rights.

ITEM 2.   MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OR   PLAN   OF
          OPERATION

NOTE REGARDING PROJECTIONS AND FORWARD LOOKING STATEMENTS

This  statement  includes  projections  of  future  results   and
"forward-looking statements" as that term is defined  in  Section
27A  of  the  Securities Act of 1933 as amended (the  "Securities
Act"), and Section 21E of the Securities Exchange Act of 1934  as
amended (the "Exchange Act"). All statements that are included in
this  Registration Statement, other than statements of historical
fact,   are   forward-looking  statements.  Although   Management
believes that the expectations reflected in these forward-looking
statements  are  reasonable, it can give no assurance  that  such
expectations  will prove to have been correct. Important  factors
that  could  cause actual results to differ materially  from  the
expectations are disclosed in this Statement, including,  without
limitation, in conjunction with those forward-looking  statements
contained in this Statement.

The  Company  plans  to  engage  in  both  wholesale  and  retail
distribution  of  herbal  products  based  on  natural  remedies.
Additional funding through private placement will be necessary to
enable  the Company to lease a suitable office warehouse facility
in  Las Vegas and to enable the Company to complete its web  page
and  to  secure  contracts  with  suppliers  and  buyers  of  the
products.

                            Liquidity

The  Company  will have to raise additional capital in  the  next
twelve  months.  As of December 31, 1999, the Company had nominal
working  capital and results.  In order to satisfy the  liquidity
needs of the Company for the following twelve months, the Company
will  be primarily dependent upon proceeds from the sale  of  the
Company's  common and/or preferred stock and possible  cash  flow
from operations.  Historically, revenues from existing operations
have not been adequate to fund the operations of the Company.  If
the  Company is unable to obtain adequate funds from the sale  of
its stock in public offerings, private placements, or alternative
financing  arrangements,  it may be  necessary  to  postpone  any
additional  acquisitions  or  the  Company's  ability  to  obtain
Letters of Credit.  The Company, under such circumstances,  would
resort to using cash flow for internal growth.

While  the Company has raised capital to meet its working capital
and financing needs, additional financing is required in order to
complete  the  planned improvements necessary  to  the  Company's
acquisitions.  The Company is seeking financing, in the  form  of
equity  and debt in order to make the necessary improvements  and
provide  working  capital.  There are no assurances  the  Company
will be successful in raising the funds required.

The  Company has issued shares of its Common Stock from  time  to
time  in  the past to satisfy certain obligations and expects  in
the future to also acquire certain services, satisfy indebtedness
and/or  make  acquisitions  utilizing authorized  shares  of  the
capital stock of the Company.  If operations and cash flow can be
improved  through  these efforts, management  believes  that  the
Company's  liquidity  problems will  be  resolved  and  that  the
Company  can continue to operate.  However, no assurance  can  be
given   that  management's  actions  will  result  in  profitable
operations.

The plan of the Company is to raise more financing as soon as the
Company's  shares are approved for trading to enable the  Company
to  enter into purchase and supply contracts.  An overall  budget
of  $650,000  for  the  first year should achieve  the  Company's
goals.  The Company does not anticipate that there will be a need
to  dramatically increase the number of employees over  the  next
twelve months.

                          Risk Factors

The  Company's  business  is subject to  numerous  risk  factors,
including the following:

NO  OPERATING HISTORY OR REVENUE AND MINIMAL ASSETS. The  Company
has  had  no  operating history and has received no  revenues  or
earnings  from operations. The Company has no significant  assets
or  financial  resources. The Company will,  in  all  likelihood,
sustain  operating  expenses without corresponding  revenues,  at
least  until it completes a business combination. This may result
in the Company incurring a net operating loss which will increase
continuously  until the Company completes a business  combination
with  a  profitable business opportunity. There is  no  assurance
that the Company will identify a business opportunity or complete
a business combination.

SPECULATIVE NATURE OF COMPANY'S PROPOSED OPERATIONS. The  success
of  the  Company's proposed plan of operation will  depend  to  a
great   extent  on  the  operations,  financial  condition,   and
management   of   the  identified  business  opportunity.   While
management  intends to seek business combinations  with  entities
having established operating histories, it cannot assure that the
Company   will   successfully  locate  candidates  meeting   such
criteria.   In  the  event  the  Company  completes  a   business
combination,  the  success  of the Company's  operations  may  be
dependent  upon  management  of the  successor  firm  or  venture
partner  firm  together with numerous other  factors  beyond  the
Company's control.

COMPETITION FOR BUSINESS OPPORTUNITIES AND COMBINATIONS. Once the
Company   begins  offering  products  for  sale,  it  will   face
competition  from  existing  suppliers.  Competition   in   these
products   is   primarily  centered  on  quality,  price,   brand
recognition and service, with an emphasis on the service.  To  be
competitive  in these marketplaces, the Company must  effectively
maintain and promote the quality of both the products and service
among consumers and establish strong marketing relationships with
manufacturers  and  distributors  of  the  products.   While  the
Company  believes that it will compete effectively, many  of  the
competitors  have  substantially  greater  resources   and   well
recognized  business  names.  The Company believes  it  can  take
advantage  of its smaller size to attract customers seeking  more
personalized  service., the Company expects to attract  customers
via  various internet search engines upon completion  of  various
web pages.

NO  AGREEMENT FOR BUSINESS COMBINATION OR OTHER TRANSACTION -  NO
STANDARDS   FOR   BUSINESS  COMBINATION.  The  Company   has   no
arrangement, agreement, or understanding with respect to engaging
in  a business combination with any private entity. There can  be
no  assurance the Company will successfully identify and evaluate
suitable   business   opportunities  or   conclude   a   business
combination.   Management  has  not  identified  any   particular
industry or specific business within an industry for evaluations.
The  Company has been in the developmental stage since  inception
and  has no operations to date. Other than issuing shares to  its
original   shareholders,   the  Company   never   commenced   any
operational activities. There is no assurance the Company will be
able  to  negotiate a business combination on terms favorable  to
the Company. The Company has not established a specific length of
operating  history or a specified level of earnings, assets,  net
worth  or  other criteria which it will require a target business
opportunity to have achieved, and without which the Company would
not  consider  a  business combination  in  any  form  with  such
business opportunity. Accordingly, the Company may enter  into  a
business  combination  with  a  business  opportunity  having  no
significant  operating history, losses, limited or  no  potential
for  earnings,  limited  assets, negative  net  worth,  or  other
negative characteristics.

CONTINUED  MANAGEMENT CONTROL, LIMITED TIME  AVAILABILITY.  While
seeking  a business combination, management anticipates  devoting
up  to twenty hours per month to the business of the Company. The
Company's  officers  have  not entered  into  written  employment
agreements with the Company and are not expected to do so in  the
foreseeable  future. The Company has not obtained  key  man  life
insurance  on  its  officers  or directors.  Notwithstanding  the
combined  limited experience and time commitment  of  management,
loss  of the services of any of these individuals would adversely
affect  development of the Company's business and its  likelihood
of continuing operations. See "MANAGEMENT."

CONFLICTS  OF  INTEREST  - GENERAL. The  Company's  officers  and
directors  participate in other business ventures  which  compete
directly  with the Company. Additional conflicts of interest  and
non  "arms-length" transactions may also arise in the  event  the
Company's officers or directors are involved in the management of
any firm with which the Company transacts business. The Company's
Board  of Directors has adopted a resolution which prohibits  the
Company  from completing a combination with any entity  in  which
management serve as officers, directors or partners, or in  which
they  or their family members own or hold any ownership interest.
Management  is  not aware of any circumstances under  which  this
policy could be changed while current management is in control of
the   Company.  See  "Item  5".  DIRECTORS,  EXECUTIVE  OFFICERS,
PROMOTERS AND CONTROL PERSONS - CONFLICTS OF INTEREST."

REPORTING   REQUIREMENTS  MAY  DELAY  OR  PRECLUDE   ACQUISITION.
Companies subject to Section 13 of the Securities Exchange Act of
1934  (the "Exchange Act") must provide certain information about
significant    acquisitions,   including   certified    financial
statements  for the company acquired, covering one or two  years,
depending on the relative size of the acquisition. The  time  and
additional costs that may be incurred by some target entities  to
prepare  such statements may significantly delay or even preclude
the  Company  from completing an otherwise desirable acquisition.
Acquisition  prospects that do not have or are unable  to  obtain
the  required  audited  statements may  not  be  appropriate  for
acquisition so long as the reporting requirements of the 1934 Act
are applicable.

LACK  OF  MARKET RESEARCH OR MARKETING ORGANIZATION. The  Company
has   not  conducted  or  received  results  of  market  research
indicating   that  market  demand  exists  for  the  transactions
contemplated by the Company. Moreover, the Company does not have,
and  does  not  plan to establish, a marketing  organization.  If
there is demand for a business combination as contemplated by the
Company,  there  is  no assurance the Company  will  successfully
complete such transaction.

LACK   OF  DIVERSIFICATION.  In  all  likelihood,  the  Company's
proposed  operations,  even  if  successful,  will  result  in  a
business  combination  with  only one entity.  Consequently,  the
resulting  activities will be limited to that entity's  business.
The Company's inability to diversify its activities into a number
of  areas may subject the Company to economic fluctuations within
a  particular business or industry, thereby increasing the  risks
associated with the Company's operations.

REGULATION.  Although the Company will be subject  to  regulation
under  the  Securities Exchange Act of 1934, management  believes
the   Company  will  not  be  subject  to  regulation  under  the
Investment Company Act of 1940, insofar as the Company  will  not
be engaged in the business of investing or trading in securities.
In  the event the Company engages in business combinations  which
result in the Company holding passive investment interests  in  a
number  of  entities, the Company could be subject to  regulation
under  the  Investment Company Act of 1940. In  such  event,  the
Company  would  be required to register as an investment  company
and  could  be  expected  to incur significant  registration  and
compliance   costs.   The   Company  has   obtained   no   formal
determination from the Securities and Exchange Commission  as  to
the  status  of the Company under the Investment Company  Act  of
1940  and, consequently, any violation of such Act would  subject
the Company to material adverse consequences.

PROBABLE CHANGE IN CONTROL AND MANAGEMENT. A business combination
involving the issuance of the Company's common stock will, in all
likelihood, result in shareholders of a private company obtaining
a   controlling  interest  in  the  Company.  Any  such  business
combination  may  require management of the Company  to  sell  or
transfer all or a portion of the Company's common stock  held  by
them,  or  resign  as members of the Board of  Directors  of  the
Company.  The  resulting change in control of the  Company  could
result  in  removal of one or more present officers and directors
of the Company and a corresponding reduction in or elimination of
their participation in the future affairs of the Company.

REDUCTION  OF  PERCENTAGE  SHARE  OWNERSHIP  FOLLOWING   BUSINESS
COMBINATION.  The  Company's primary plan of operation  is  based
upon a business combination with a private concern which, in  all
likelihood,  would  result in the Company issuing  securities  to
shareholders   of   such  private  company.  Issuing   previously
authorized  and unissued common stock of the Company will  reduce
the  percentage  of  shares  owned  by  present  and  prospective
shareholders,  and  a  change  in the  Company's  control  and/or
management.

TAXATION.  Federal  and  state  tax  consequences  will,  in  all
likelihood,  be major considerations in any business  combination
the  Company may undertake. Typically, these transactions may  be
structured  to  result in tax-free treatment to  both  companies,
pursuant to various federal and state tax provisions. The Company
intends  to structure any business combination so as to  minimize
the  federal  and state tax consequences to both the Company  and
the  target  entity.  Management cannot assure  that  a  business
combination will meet the statutory requirements for  a  tax-free
reorganization, or that the parties will obtain the intended tax-
free  treatment  upon  a  transfer of stock  or  assets.  A  non-
qualifying reorganization could result in the imposition of  both
federal and state taxes, which may have an adverse effect on both
parties to the transaction.

REQUIREMENT  OF  AUDITED  FINANCIAL  STATEMENTS  MAY   DISQUALIFY
BUSINESS  OPPORTUNITIES. Management believes that  any  potential
target  company  must  provide audited financial  statements  for
review,  and  for the protection of all parties to  the  business
combination.  One  or more attractive business opportunities  may
forego a business combination with the Company, rather than incur
the   expenses   associated  with  preparing  audited   financial
statements.

BLUE   SKY  CONSIDERATIONS.  Because  the  securities  registered
hereunder have not been registered for resale under the blue  sky
laws  of  any  state,  and the Company has no  current  plans  to
register  or  qualify its shares in any state, holders  of  these
shares  and  persons who desire to purchase them in  any  trading
market  that  might develop in the future, should be  aware  that
there  may  be significant state blue sky restrictions  upon  the
ability  of  new  investors  to purchase  the  securities.  These
restrictions could reduce the size of any potential market. As  a
result  of  recent changes in federal law, non-issuer trading  or
resale   of  the  Company's  securities  is  exempt  from   state
registration  or  qualification  requirements  in  most   states.
Accordingly,  investors should consider any  potential  secondary
market for the Company's securities to be a limited one.

ITEM 3.   DESCRIPTION OF PROPERTY.

The  Company's principal executive and administrative offices are
temporarily  located at 886 Calverhill Street,  North  Vancouver,
BC,  Canada  V7L  1X9, which is provided by the President  at  no
charge to the Company.  The Company also uses shared office space
with  secretarial services located at 3651 Lindell Rd., Suite  A,
Las Vegas, Nevada 89103 at no cost to the Company, and Management
expects  this arrangement to continue. The Company pays  its  own
charges for long distance telephone calls and other miscellaneous
secretarial, photocopying, and similar expenses. This is a verbal
agreement  between  Vegas  Commerce  Center  and  the  Board   of
Directors.

ITEM 4.   SECURITY  OWNERSHIP  OF CERTAIN BENEFICIAL  OWNERS  AND
          MANAGEMENT.

None of the officers or directors own any of the Company's Common
Stock.  There are no individuals who own five percent (5%) of the
Company's Common Stock.

 ITEM 5.  DIRECTORS,  EXECUTIVE OFFICERS, PROMOTERS, AND  CONTROL
          PERSONS

The  members of the Board of Directors of the Company serve until
the  next  annual  meeting of the stockholders,  or  until  their
successors have been elected. The officers serve at the  pleasure
of the Board of Directors.

There are no agreements for any officer or director to resign  at
the  request  of  any other person, and none of the  officers  or
directors  named  below  are acting  on  behalf  of,  or  at  the
direction of, any other person.

The  Company's officers and directors will devote their  time  to
the  business  on  an  "as-needed" basis, which  is  expected  to
require 5-10 hours per month.

Information  as  to the directors and executive officers  of  the
Company is as follows:

<TABLE>

<S>                      <C>               <C>

Name/Address             Age               Position
Patricia Wiate           46                President, Secretary,
                                           Treasurer and
                                           Director
</TABLE>

Patricia Wiate; President, Secretary, Treasurer and Director

Ms.  Wiate  has  been  the  President, Secretary,  Treasurer  and
Director of the Company since incorporation on December 3,  1998.
Ms.  Wiate  has  been  involved in  retail  sales  and  marketing
including  pottery  from 1989 through 1996  and  wine  from  1997
through  1999.   Prior to that time she studied  wine  in  Europe
while her husband was in the military.

There  are  no promoters of the Company. The Company's  Board  of
Directors has not established any committees.

                      Conflicts of Interest

Certain  conflicts  of interest now exist and  will  continue  to
exist  between the Company and its officers and directors due  to
the fact that Ms. Wiate has other business interests to which she
devotes her primary attention.  Ms. Wiate may continue to do  so,
notwithstanding the fact that management time should  be  devoted
to  the  business  of the Company. Ms. Wiate may  in  the  future
become  a  shareholder, officer or director  of  other  companies
which  may  be  formed  for the purpose of engaging  in  business
activities similar to those conducted by the Company. The Company
does  not  currently have a right of first refusal pertaining  to
opportunities that come to management's attention insofar as such
opportunities  may  relate  to  the Company's  proposed  business
operations.

Ms.  Wiate so long as she remains an officer or director  of  the
Company,  is  subject to the restriction that  all  opportunities
contemplated by the Company's plan of operation which come to her
attention,  either in the performance of her  duties  or  in  any
other  manner, will be considered opportunities of, and  be  made
available to the Company and the companies that she is affiliated
with  on an equal basis. A breach of this requirement will  be  a
breach of the fiduciary duties of the officer or director.

                 Investment Company Act of 1940

Although  the  Company  will be subject to regulation  under  the
Securities Act of 1933 and the Securities Exchange Act  of  1934,
management believes the Company will not be subject to regulation
under  the Investment Company Act of 1940 insofar as the  Company
will  not  be engaged in the business of investing or trading  in
securities.  In  the  event  the  Company  engages  in   business
combinations   which  result  in  the  Company  holding   passive
investment  interests in a number of entities, the Company  could
be  subject  to  regulation under the Investment Company  Act  of
1940. In such event, the Company would be required to register as
an  investment company and could be expected to incur significant
registration  and compliance costs. The Company has  obtained  no
formal  determination from the Securities and Exchange Commission
as  to the status of the Company under the Investment Company Act
of  1940  and,  consequently, any violation  of  such  Act  would
subject the Company to material adverse consequences.

ITEM 6.   EXECUTIVE COMPENSATION

The  Company's  officer  and/or director  has  not  received  any
compensation  for her services rendered to the Company,  nor  has
she received such compensation in the past. She has agreed to act
without  compensation until authorized by the Board of Directors,
which is not expected to occur until the Registrant has generated
revenues  from  operations. As of the date of  this  registration
statement,  the Company has no funds available to pay  Ms.  Wiate
and  she  is  not  accruing  any  compensation  pursuant  to  any
agreement with the Company.

No retirement, pension, profit sharing, stock option or insurance
programs  or  other  similar programs have been  adopted  by  the
Registrant for the benefit of its employees.

ITEM 7.   CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

None.

ITEM 8.   LEGAL PROCEEDINGS

The  Company  is  not  a  party  to any  material  pending  legal
proceedings and, to the best of its knowledge, no such action  by
or against the Company has been threatened.

ITEM 9.   MARKET   FOR  COMMON  EQUITY  AND  RELATED  STOCKHOLDER
          MATTERS.

The  Company's  common stock is not yet quoted on any  market  or
quotation  system  in  the  United  States.  Management  has  not
undertaken  any discussions, preliminary or otherwise,  with  any
prospective  market  maker concerning the participation  of  such
market maker in the after-market for the Company's securities.

                          Market Price

The Registrant's Common Stock is not quoted at the present time.

Effective August 11, 1993, the Securities and Exchange Commission
adopted Rule 15g-9, which established the definition of a  "penny
stock,"  for  purposes  relevant to the Company,  as  any  equity
security that has a market price of less than $5.00 per share  or
with  an exercise price of less than $5.00 per share, subject  to
certain exceptions. For any transaction involving a penny  stock,
unless  exempt,  the rules require: (i) that a broker  or  dealer
approve a person's account for transactions in penny stocks;  and
(ii)  the  broker or dealer receive from the investor  a  written
agreement  to  the  transaction, setting forth the  identity  and
quantity of the penny stock to be purchased. In order to  approve
a  person's account for transactions in penny stocks, the  broker
or  dealer  must (i) obtain financial information and  investment
experience  and  objectives  of  the  person;  and  (ii)  make  a
reasonable  determination that the transactions in  penny  stocks
are  suitable  for  that  person and that person  has  sufficient
knowledge  and experience in financial matters to be  capable  of
evaluating the risks of transactions in penny stocks. The  broker
or  dealer must also deliver, prior to any transaction in a penny
stock,  a disclosure schedule prepared by the Commission relating
to  the  penny stock market, which, in highlight form,  (i)  sets
forth  the  basis  on  which  the  broker  or  dealer  made   the
suitability  determination; and (ii) that the  broker  or  dealer
received  a signed, written agreement from the investor prior  to
the  transaction. Disclosure also has to be made about the  risks
of  investing  in  penny stocks in both public offerings  and  in
secondary  trading,  and about commissions payable  to  both  the
broker-dealer   and   the   registered  representative,   current
quotations  for  the  securities  and  the  rights  and  remedies
available  to  an  investor in cases  of  fraud  in  penny  stock
transactions.  Finally,  monthly  statements  have  to  be   sent
disclosing recent price information for the penny stock  held  in
the  account  and  information on the  limited  market  in  penny
stocks.

The   National  Association  of  Securities  Dealers,  Inc.  (the
"NASD"),  which administers NASDAQ, has recently made changes  in
the  criteria for initial listing on the NASDAQ Small Cap  market
and  for  continued listing. For initial listing, a company  must
have net tangible assets of $4 million, market capitalization  of
$50  million  or  net  income of $750,000 in  the  most  recently
completed  fiscal year or in two of the last three fiscal  years.
For  initial listing, the common stock must also have  a  minimum
bid price of $4 per share. In order to continue to be included on
NASDAQ, a company must maintain $2,000,000 in net tangible assets
and  a $1,000,000 market value of its publicly-traded securities.
In addition, continued inclusion requires two market-makers and a
minimum bid price of $1.00 per share.

Management intends to strongly consider undertaking a transaction
with  any  merger or acquisition candidate which will  allow  the
Company's   securities  to  be  traded  without   the   aforesaid
limitations.  However, there can be no assurances  that,  upon  a
successful  merger or acquisition, the Company will  qualify  its
securities for listing on NASDAQ or some other national exchange,
or  be  able  to maintain the maintenance criteria  necessary  to
insure  continued listing. The failure of the Company to  qualify
its securities or to meet the relevant maintenance criteria after
such qualification in the future may result in the discontinuance
of  the  inclusion  of  the Company's securities  on  a  national
exchange.  In  such  events, trading, if any,  in  the  Company's
securities  may  then continue in the non-NASDAQ over-the-counter
market. As a result, a shareholder may find it more difficult  to
dispose  of,  or to obtain accurate quotations as to  the  market
value of, the Company's securities.

                             Holders

There  are 47 holders of the Company's Common Stock. The  company
issued 100,000 shares of Common Stock on December 31, 1998 and an
additional  30,000 shares of Common Stock on November  12,  1999.
The  Company  also issued and sold 100,000 shares  on  March  23,
1999, pursuant to a Rule 504 of Regulation D Offering promulgated
under  the Securities Act.  These shares were issued for a  price
of  $0.10  per  share pursuant to an exemption from  registration
provided  by  Section  4(2) of the Securities  Act  of  1933,  as
amended (the "Securities Act").

On  December  31, 1998, the Company issued the following  shares:
5,000  to  Maria  Aguilar; 10,000 to Kim Chan;  10,000  to  Roger
Farmer;  5,000 to Martin Kay; 7,500 to Sharon Kennedy;  5,000  to
John Lynch; 10,000 to William Miller; 5,000 to David Owens; 7,500
to  Christine  Roberts; 10,000 to Jesus Sanchez;  7,500  to  Mary
Sullivan; 7,500 to Mark Ventura; and 10,000 to Chi Yang.

On March 23, 1999, pursuant to an executed Subscription Agreement
at  the price of $.10 per share, the Company issued the following
shares:  2,000 to Sarah Adams; 3,000 to William Bruce;  5,000  to
David   Cardenas;  4,000  to  John  Daniels;  3,000  to   Shirley
Dickenson; 5,000 to James Elliott; 5,000 to Julia Evans; 2,000 to
Jesse  Graham; 2,500 to Susan Hahn; 3,000 to Michael Hall;  5,000
to  Dennis  Harrison; 2,500 to Gary Lawson; 4,000 to John  Lucas;
4,500  to Michelle Mahoney; 5,000 to Charles Mann; 3,000 to  Anna
Marshall;  2,500 to Jose Martinez; 5,000 to Joseph Murphy;  3,000
to  Nancy  Nash; 2,000 to Heather Nelson; 3,000 to Diane  Oliver;
2,000  to  Juan  Ortega; 3,000 to John Parker; 3,000  to  William
Parks; 1,500 to John Richardson; 4,000 to Robert Rivera; 1,500 to
Robert Shannon; 2,500 to Patricia Smith; 1,500 to Antonio Torres;
2,000  to  Charles  Tucker;  1,500 to John  Valentine;  3,000  to
Michael Ward and 2,000 to David Wright.

On  November 12, 1999, the Company issued 30,000 shares  to  Bill
Aaron.

                            Dividends

The  Registrant has not paid any dividends to date,  and  has  no
plans to do so in the immediate future.

ITEM 10.  RECENT SALES OF UNREGISTERED SECURITIES.

The  Company has not agreed to register any shares of its  common
stock for any shareholder.  There are presently 230,000 shares of
common  stock  outstanding.  Of these, a total of 130,000  shares
are  restricted  pursuant  to  Rule  144  promulgated  under  the
Securities Act.

On  December  31, 1998, the Company issued the following  shares:
5,000  to  Maria  Aguilar; 10,000 to Kim Chan;  10,000  to  Roger
Farmer;  5,000 to Martin Kay; 7,500 to Sharon Kennedy;  5,000  to
John Lynch; 10,000 to William Miller; 5,000 to David Owens; 7,500
to  Christine  Roberts; 10,000 to Jesus Sanchez;  7,500  to  Mary
Sullivan; 7,500 to Mark Ventura; and 10,000 to Chi Yang.

On March 23, 1999, pursuant to an executed Subscription Agreement
at  the price of $.10 per share, the Company issued the following
shares:  2,000 to Sarah Adams; 3,000 to William Bruce;  5,000  to
David   Cardenas;  4,000  to  John  Daniels;  3,000  to   Shirley
Dickenson; 5,000 to James Elliott; 5,000 to Julia Evans; 2,000 to
Jesse  Graham; 2,500 to Susan Hahn; 3,000 to Michael Hall;  5,000
to  Dennis  Harrison; 2,500 to Gary Lawson; 4,000 to John  Lucas;
4,500  to Michelle Mahoney; 5,000 to Charles Mann; 3,000 to  Anna
Marshall;  2,500 to Jose Martinez; 5,000 to Joseph Murphy;  3,000
to  Nancy  Nash; 2,000 to Heather Nelson; 3,000 to Diane  Oliver;
2,000  to  Juan  Ortega; 3,000 to John Parker; 3,000  to  William
Parks; 1,500 to John Richardson; 4,000 to Robert Rivera; 1,500 to
Robert Shannon; 2,500 to Patricia Smith; 1,500 to Antonio Torres;
2,000  to  Charles  Tucker;  1,500 to John  Valentine;  3,000  to
Michael Ward and 2,000 to David Wright.

On  November 12, 1999, the Company issued 30,000 shares  to  Bill
Aaron.

In general, under Rule 144, a person (or persons whose shares are
aggregated)  who has satisfied a one year holding  period,  under
certain  circumstances, may sell within any three-month period  a
number of shares which does not exceed the greater of one percent
of  the  then  outstanding Common Stock  or  the  average  weekly
trading volume during the four calendar weeks prior to such sale.
Rule  144 also permits, under certain circumstances, the sale  of
shares  without  any  quantity limitation by  a  person  who  has
satisfied a two-year holding period and who is not, and  has  not
been for the preceding three months, an affiliate of the Company.

ITEM 11.  DESCRIPTION OF SECURITIES.

                          Common Stock

The  Company's Articles of Incorporation authorizes the  issuance
of  50,000,000 shares of Common stock, par value $.001 per share,
of  which 230,000 are issued and outstanding. The shares are non-
assessable,  without  pre-emptive  rights,  and  do   not   carry
cumulative  voting rights. Holders of common shares are  entitled
to  one vote for each share on all matters to be voted on by  the
stockholders. The shares are fully paid, non-assessable,  without
pre-emptive  rights, and do not carry cumulative  voting  rights.
Holders  of  common  shares  are entitled  to  share  ratably  in
dividends, if any, as may be declared by the Company from time-to-
time,   from  funds  legally  available.  In  the  event   of   a
liquidation,  dissolution, or winding  up  of  the  Company,  the
holders of shares of common stock are entitled to share on a pro-
rata  basis  all assets remaining after payment in  full  of  all
liabilities.

Management  is not aware of any circumstances in which additional
shares  of  any class or series of the Company's stock  would  be
issued to management or promoters, or affiliates or associates of
either.

ITEM 12.  INDEMNIFICATION OF DIRECTORS AND OFFICERS.

The  Company  and  its  affiliates  may  not  be  liable  to  its
shareholders  for errors in judgment or other acts  or  omissions
not  amounting  to intentional misconduct, fraud,  or  a  knowing
violation  of  the law, since provisions have been  made  in  the
Articles  of  Incorporation and By-laws limiting such  liability.
The  Articles  of  Incorporation and  By-laws  also  provide  for
indemnification of the officers and directors of the  Company  in
most  cases  for any liability suffered by them or  arising  from
their activities as officers and directors of the Company if they
were  not engaged in intentional misconduct, fraud, or a  knowing
violation  of the law. Therefore, purchasers of these  securities
may  have  a  more limited right of action than they  would  have
except  for this limitation in the Articles of Incorporation  and
By-laws.

The  officers and directors of the Company are accountable to the
Company  as fiduciaries, which means such officers and  directors
are required to exercise good faith and integrity in handling the
Company's  affairs. A shareholder may be able to institute  legal
action  on  behalf  of  himself and all others  similarly  stated
shareholders to recover damages where the Company has  failed  or
refused to observe the law.

Shareholders may, subject to applicable rules of civil procedure,
be  able  to  bring a class action or derivative suit to  enforce
their  rights, including rights under certain federal  and  state
securities  laws and regulations. Shareholders who have  suffered
losses  in connection with the purchase or sale of their interest
in  the  Company  in  connection  with  such  sale  or  purchase,
including  the misapplication by any such officer or director  of
the  proceeds from the sale of these securities, may be  able  to
recover such losses from the Company.

ITEM 13.  FINANCIAL STATEMENTS.

The  financial statements and supplemental data required by  this
Item  13  follow the index of financial statements  appearing  at
Item 15 of this Form 10-SB.

ITEM 14.  CHANGES  IN  AND  DISAGREEMENTS  WITH  ACCOUNTANTS   ON
          ACCOUNTING AND FINANCIAL DISCLOSURE.

The  Registrant has not changed accountants since its  formation,
and  Management has had no disagreements with the findings of its
accountants.

ITEM 15.  FINANCIAL STATEMENTS AND EXHIBITS.

FINANCIAL STATEMENTS

          Report of Independent Auditors, dated June 2, 2000

          Balance  Sheet  as of December 31, 1998,  December  31,
            1999 and
            March 31, 2000

          Statement of Operation for the years ended December 31,
            1998 and December 31, 1999

          Statement of Stockholders' Equity

          Statement  of  Cash Flows for the years ended  December
            31, 1998 and December 31, 1999

          Notes to Financial Statements

                 INDEPENDENT ACCOUNTANT'S REPORT

To the Board of Directors and Stockholders
of Holmes Herbs, Inc.
Las Vegas, Nevada

     I have audited the accompanying balance sheets of Holmes
Herbs, Inc. (a development stage company) as of March 31, 2000,
and March 31, 1999, and the related statements of operations,
cash flows, and changes in stockholders' equity for the period
from December 3, 1998 (date of inception) to March 31, 2000.
These statements are the responsibility of Holmes Herbs, Inc.'s
management. My responsibility is to express an opinion on these
financial statements based on my audit.

     I conducted my audit in accordance with generally accepted
auditing standards. Those standards require that I plan and
perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement. An
audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit
also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating
the overall financial statement presentation. I believe that my
audit provides a reasonable basis for my opinion.

     In my opinion, the accompanying financial statements present
fairly, in all material respects, the financial position of
Holmes Herbs, Inc. as of March 31, 2000, and March 31, 1999, and
the results of operations, cash flows, and changes in
stockholders' equity for the periods then ended, as well as the
cumulative period from December 3, 1998, in conformity with
generally accepted accounting principles.

David Coffey, C. P. A.
Las Vegas, Nevada
June 2, 2000

HOLMES HERBS, INC.
( A DEVELOPMENT STAGE COMPANY )
BALANCE SHEETS
<TABLE>
<S>                        <   <C>            <  <C>
                           C                  C
                           >                  >

                                 March 31,        March
                                                   31,
                                    2000            1999
ASSETS                          ------------      ---------

Cash                       $              41  $          71
                                ------------      ---------
 Total Assets              $              41  $          71
                                  ==========      =========

LIABILITIES &
STOCKHOLDERS' EQUITY

Accounts payable           $           1,400  $         400
                                ------------      ---------
 Total Liabilities                     1,400            400

Stockholders' Equity
 Common stock, authorized
 50,000,000 shares at .001
par value,
 230,000 and 200,000
shares, respectively,
 issued and outstanding                  230            200
 Additional paid-in                    3,620          3,650
capital
 Deficit accumulated
during the
 development stage                   (5,209)        (4,179)
                                ------------      ---------
   Total Stockholders'               (1,359)          (329)
Equity


 Total Liabilities and     $              41  $          71
Stockholders' Equity

</TABLE>



The accompanying notes are an integral part of
these financial statements.



                             -  2  -



HOLMES HERBS, INC.
( A DEVELOPMENT STAGE COMPANY )
STATEMENTS OF OPERATIONS AND DEFICIT
ACCUMULATED DURING THE DEVELOPMENT STAGE
( With Cumulative Figures From Inception )
<TABLE>
<S>                      <<C>            <  <C>           <<C>
                         C               C                C
                         >               >                >

                                                               From
                                                           Inception,
                           Jan. 1, 2000,       Jan. 1,      Dec. 3, 1998
                                to            1999, to          To
                           Mar. 31, 2000       Mar. 31,       Mar. 31,
                                                1999           2000
                           -------------     ------------   ------------
Income                   $             0 $                $            0

Expenses
 Office and                             0           3,779           3,809
administrative expenses
 Professional fees                  1,000               0           1,000
 Organizational costs                   0               0             400
                               ----------      ----------      ----------
Total expenses                      1,000           3,779           5,209

Net loss                          (1,000)         (3,779)         (5,209)
                                                           $     ========

Retained earnings,                (4,209)           (400)
beginning of period
                               ----------      ----------
Deficit accumulated
during the
development stage        $       (5,209) $       (4,179)
                                 ========        ========


Earnings ( loss ) per
share
assuming dilution:
Net loss                 $          0.00 $        (0.03)  $       (0.02)
                                 ========        ========        ========

Weighted average shares           230,000         133,333         178,125
outstanding
                                 ========        ========        ========
</TABLE>

The accompanying notes are an integral part of
these financial statements.

                              - 3 -
HOLMES HERBS, INC.
( A DEVELOPMENT STAGE COMPANY )
STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
FOR THE PERIOD FROM DECEMBER 3, 1998  ( Date of Inception )
TO MARCH 31, 2000

<TABLE>
<S>                <C>           < <C>          < <C>          <<C>
                                 C              C              C
                                 >              >              >


                           Common Stock           Additional       Total
                      Shares          Amount        Paid-in
                                                    Capital
                   -----------     -----------    -----------   ----------
                                 $              $              $
Balance,
December 3, 1998         -----            -----         -----         -----

Issuance of
common
stock for cash
December 31, 1998      100,000              100             0           100

Less net loss                0                0             0         (400)
                     ---------        ---------     ---------     ---------
Balance,
December 31, 1998      100,000   $          100 $           0  $      (300)

Issuance of
common
stock for cash
March 23, 1999         100,000              100         9,900        10,000

Issuance of
common
stock for cash          30,000               30         2,970         3,000
Nov. 10, 1999

Less offering                0                0       (9,250)       (9,250)
costs

Less net loss                0                0             0       (3,809)
                     ---------        ---------     ---------     ---------
Balance,
December 31, 1999      230,000              230         3,620         (359)

Less net loss                0                0             0       (1,000)
                     ---------        ---------     ---------     ---------
Balance,
March 31, 2000         230,000   $          230 $       3,620  $    (1,359)
                      ========         ========      ========      ========
</TABLE>

The accompanying notes are an integral part of
these financial statements

                              - 4 -



HOLMES HERBS, INC.
( A DEVELOPMENT STAGE COMPANY )
STATEMENTS OF CASH FLOWS
( With Cumulative Figures From Inception )
<TABLE>
<S>                           < <C>            < <C>           <  <C>
                              C                C               C
                              >                >               >
                                                                      From
                                                                   Inception,
                                Jan. 1, 2000,       Jan. 1,        Dec. 3,
                                      to           1999, to         1998
                                Mar. 31, 2000      Mar. 31,       To Mar. 31,
                                                     1999             2000
                                 -----------     ------------     ------------
CASH FLOWS PROVIDED BY
OPERATING

ACTIVITIES
Net Loss                      $        (1,000) $       (3,779) $       (4,209)
Non-cash items included in
net loss
Adjustments to reconcile net
loss to
 cash used by operating
activity
   Accounts payable                       1,000               0             400
                                     ----------       ---------    ------------
     NET CASH PROVIDED BY
     OPERATING ACTIVITIES                     0         (3,779)         (3,809)

CASH FLOWS FROM INVESTING                     0               0               0
ACTIVITIES

CASH FLOWS FROM FINANCING
ACTIVITIES
   Sale of common stock                       0             100             230
   Paid-in capital                            0           9,900          12,870
   Less offering costs                        0         (6,250)         (9,250)
                                     ----------       ---------    ------------
     NET CASH PROVIDED BY
     FINANCING ACTIVITIES                     0           3,750           3,850

     NET INCREASE IN CASH                     0            (29) $            41
                                                                     ==========
CASH AT BEGINNING OF PERIOD                  41             100
                                    -----------       ---------
     CASH AT END OF PERIOD    $             41 $            71
                                       ========        ========
</TABLE>

The accompanying notes are an integral part of
these financial statements.



                              - 5 -



HOLMES HERBS, INC.
( A DEVELOPMENT STAGE COMPANY )
NOTES TO THE FINANCIAL STATEMENTS
MARCH 31, 2000, AND MARCH 31, 1999



NOTE A SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

  The Company was incorporated on December 3, 1998, under  the
laws of the State of Nevada. The business purpose of  the Company
is to procure and resell herbal remedies.

 The Company will adopt accounting policies and procedures  based
upon the nature of future transactions.

NOTE B OFFERING COSTS

 Offering costs were deducted from the proceeds of the  public
offering.

NOTE C EARNINGS (LOSS) PER SHARE

 Basic EPS is determined using net income divided by the
weighted average shares outstanding during the period.  Diluted
EPS is computed by dividing net income by the  weighted average
shares outstanding, assuming all dilutive  potential common
shares were issued. Since the Company  has no common shares that
are potentially issuable, such as  stock options, convertible
securities or warrants, basic and  diluted EPS are the same.

NOTE D COMMON STOCK ISSUES

 On March 23, 1999, the Company completed the sale of  100,000
shares of it's common stock at $.10 per share for  total proceeds
of $10,000. The net proceeds were to be used  for marketing of
herbal remedies.

 On November 10, 1999, the Company sold by private placement
30,000 common shares at $.10 per share for a total of  $3,000.
The proceeds were to be used for working  capital.



                              - 6 -

                            EXHIBITS

          3.1 Articles of Incorporation

          3.2  By-Laws



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission